Dewpoint Therapeutics raises $60 mln

Dewpoint Therapeutics said Jan. 30 it raised $60 million in Series A funding led by Polaris Partners. Also investing were Samsara BioCapital, 6 Dimensions Capital, EcoR1 Capital, Alexandria Venture Investments, and Leaps by Bayer. Dewpoint Therapeutics is developing drugging condensates.